Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M448Revenue (TTM) $M157Net Margin (%)-36.0Altman Z-Score0.5
Enterprise Value $M395EPS (TTM) $-0.8Operating Margin %-30.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-36.0Higher ROA y-yN
Price/Book1.810-y EBITDA Growth Rate %--Quick Ratio3.4Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %--Current Ratio3.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-321.2ROA % (ttm)-13.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-25.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M80.2ROIC % (ttm)-26.4Gross Margin Increase y-yN

Gurus Latest Trades with SPPI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SPPIJoel Greenblatt 2016-06-30 Buy $6.33 - $7.65
($7.06)
$ 5.59-21%New holding39,070
SPPIJoel Greenblatt 2012-12-31 Sold Out -0.02%$10.64 - $12.31
($11.39)
$ 5.59-51%Sold Out0
SPPIJoel Greenblatt 2012-09-30 Buy 0.02%$11.6 - $17.05
($13.85)
$ 5.59-60%New holding19,901
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SPPI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SPPI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MAIDA ANTHONY E IIIDirector 2013-03-05Sell5,000$11.5-51.39view
MAIDA ANTHONY E IIIDirector 2013-02-05Sell5,000$12.25-54.37view
MAIDA ANTHONY E IIIDirector 2013-01-02Sell5,000$11.42-51.05view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-12-31Sell378,343$11.29-50.49view
MAIDA ANTHONY E IIIDirector 2012-12-04Sell5,000$11.65-52.02view
Keller Joseph KennethEVP & COO 2012-11-12Buy10,000$10.95-48.95view
MAIDA ANTHONY E IIIDirector 2012-11-01Sell5,000$11.09-49.59view
SHROTRIYA RAJESH C MDChairman, CEO & President 2012-10-09Sell11,350$12.5-55.28view
MAIDA ANTHONY E IIIDirector 2012-10-02Sell5,000$11.8-52.63view
Scott Brett LActing CFO 2012-10-01Sell6,000$12-53.42view

Quarterly/Annual Reports about SPPI:

News about SPPI:

Articles On GuruFocus.com
AT&T Will Benefit From DirecTV Acquistion Aug 14 2015 
Spectrum: Allos Acquisition Means Huge Upside Potential May 04 2012 
5 Stocks Exceeding Expectations In 2012 Mar 31 2012 
Was Gilead's Acquisition of Pharmasset a Dose of Bad Medicine? Mar 05 2012 
Spectrum Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 10 2011 
Weekly CFO Buys Highlight: CNYD, PRWT, ANCB, SPPI, SPAX Jan 30 2011 
Weekly CFO Buys Highlight: FUL, SPPI, GRF, BPAX Jan 24 2011 
Weekly Top Insider Buys: NPBC, FUL, GAM, SHLM, SPPI Jan 23 2011 
Spectrum Pharmaceuticals Inc. (SPPI) CFO Brett L Scott buys 4,000 Shares Jan 21 2011 
Spectrum Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 

More From Other Websites
Our Take On Spectrum Pharmaceuticals, Inc. (SPPI)’s Near Term Panel Review Aug 23 2016
SPECTRUM PHARMACEUTICALS INC Financials Aug 18 2016
ETF’s with exposure to Spectrum Pharmaceuticals, Inc. : August 15, 2016 Aug 15 2016
Spectrum Pharmaceuticals, Inc. :SPPI-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12,... Aug 12 2016
Spectrum Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SPPI-US :... Aug 11 2016
Spectrum Pharmaceuticals Reports Second Quarter 2016 Financial Results and Pipeline Update Aug 09 2016
Spectrum Pharma reports 2Q loss Aug 09 2016
Spectrum Pharma reports 2Q loss Aug 09 2016
SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 09 2016
Spectrum Pharmaceuticals Reports Second Quarter 2016 Financial Results and Pipeline Update Aug 09 2016
Q2 2016 Spectrum Pharmaceuticals Inc Earnings Release - Time Not Supplied Aug 09 2016
ETF’s with exposure to Spectrum Pharmaceuticals, Inc. : August 4, 2016 Aug 04 2016
Spectrum Pharmaceuticals Announces Second Quarter 2016 Financial Results Teleconference and Webcast Aug 02 2016
Spectrum Pharmaceuticals Announces Second Quarter 2016 Financial Results Teleconference and Webcast Aug 02 2016
ETF’s with exposure to Spectrum Pharmaceuticals, Inc. : July 20, 2016 Jul 20 2016
Spectrum Pharmaceuticals Settles FOLOTYN® (pralatrexate injection) ANDA Patent Litigation Jul 13 2016
Spectrum Pharmaceuticals Settles FOLOTYN® (pralatrexate injection) ANDA Patent Litigation Jul 13 2016
SPECTRUM PHARMACEUTICALS INC Files SEC form 8-K, Other Events Jul 13 2016
ETF’s with exposure to Spectrum Pharmaceuticals, Inc. : July 6, 2016 Jul 06 2016
Spectrum Pharmaceuticals to Present Corporate Update at the Cantor Fitzgerald's 2nd Annual... Jul 06 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)